Provided herein is a copolymer that includes a soft block (A) that contains poly(ester amide) (PEA) and a hard block (B). The copolymer can be any of AB, ABA or BAB type block copolymers. By varying the relative amount of the PEA block and the hard block, one can obtain a copolymer with a T
g
for mechanical integrity in drug-delivery stent applications. The copolymer can be used alone or optionally in combination with a biobeneficial material and/or a biocompatible polymer to form an implantable device or a coating on an implantable device. When the copolymer is used in combination with a biobeneficial material, the copolymer and the biobeneficial material can be co-deposited or applied in sequence during the coating process. A coating formed of the copolymer may also include a bioactive agent. The implantable device can be implanted in a patient to treat, prevent, or ameliorate a disorder such as atherosclerosis, thrombosis, restenosis, hemorrhage, vascular dissection or perforation, vascular aneurysm, vulnerable plaque, chronic total occlusion, claudication, anastomotic proliferation for vein and artificial grafts, bile duct obstruction, ureter obstruction, and/or tumor obstruction.
本文提供的共聚物包括含有聚(酯酰胺)(
PEA)的软嵌段(A)和硬嵌段(B)。该共聚物可以是 AB、ABA 或 BAB 型嵌段共聚物中的任何一种。通过改变
PEA 嵌段和硬嵌段的相对含量,可以得到一种共聚物,其 T
g
的共聚物,以满足给药支架应用中的机械完整性要求。共聚物可单独使用,也可与
生物有益材料和/或
生物相容性聚合物结合使用,以形成植入装置或植入装置涂层。当共聚物与
生物益性材料结合使用时,共聚物和
生物益性材料可在涂层过程中依次共同沉积或应用。由共聚物形成的涂层还可包括
生物活性剂。可植入装置可植入患者体内,以治疗、预防或改善动脉粥样硬化、血栓形成、血管再狭窄、出血、血管剥离或穿孔、血管动脉瘤、易损斑块、慢性全闭塞、跛行、静脉和人工移植物吻合口增生、胆管阻塞、输尿管阻塞和/或肿瘤阻塞等疾病。